Vivacelle Bio, Inc. Employee Directory

Biotechnology ResearchIllinois, United States11-50 Employees

Vivacelle Bio, Inc. is a biotechnology research company focused on developing products that use nanoparticle technology to address hypovolemia, a condition characterized by inadequate blood volume. Its lead product, VBI-1, is a colloid volume expander that aims to safer and more effective fluid resuscitation, with FDA clearance to begin a phase IIa trial for hypovolemia due to blood loss; the pipeline also includes VBI-S targeting hypovolemia from sepsis and septic shock. The company positions itself within the biotechnology field by pursuing therapies that modulate vascular volume and related inflammatory processes, potentially improving outcomes in acute care scenarios where rapid volume replacement is critical. Based in Chicago, Illinois, with a development focus on next-generation fluid resuscitation, Vivacelle Bio operates as a developmental-stage venture working to advance solutions for shock and trauma. Recent activity includes participating in BIO Partnering @ JPM Week 2025, signaling ongoing business development activities around its late-stage program for shock and trauma care.

Sign up for free to view info

Company overview Email format